
Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2022 Update
Description
Summary
Meril Life Sciences Pvt Ltd (Meril) is a company that designs, develops and manufactures medical devices. It offers vascular intervention devices such as stents, scaffolds, catheters, inflation and vascular closure devices; and orthopedic implants such as knee and hip replacement systems and instrument sets. Its diagnostic product range includes analyzers, reagents for clinical biochemistry, haematology, immunology, rapids, critical care, diabetes management, coagulation and lab consumables. Meril also provides surgical and ophthalmic sutures, biosurgicals, hernia repair, cardiac, airway management, nasal packing, tonsils and adenoids treatment solutions. The company operates subsidiaries in India, the US, Germany, Brazil, Russia, South Africa, Bangladesh and Turkey. Meril is headquartered in Vapi, Gujarat, India.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Meril Life Sciences Pvt Ltd (Meril) is a company that designs, develops and manufactures medical devices. It offers vascular intervention devices such as stents, scaffolds, catheters, inflation and vascular closure devices; and orthopedic implants such as knee and hip replacement systems and instrument sets. Its diagnostic product range includes analyzers, reagents for clinical biochemistry, haematology, immunology, rapids, critical care, diabetes management, coagulation and lab consumables. Meril also provides surgical and ophthalmic sutures, biosurgicals, hernia repair, cardiac, airway management, nasal packing, tonsils and adenoids treatment solutions. The company operates subsidiaries in India, the US, Germany, Brazil, Russia, South Africa, Bangladesh and Turkey. Meril is headquartered in Vapi, Gujarat, India.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
59 Pages
- Meril Life Sciences Pvt Ltd Company Overview
- Meril Life Sciences Pvt Ltd Company Snapshot
- Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Meril Life Sciences Pvt Ltd – Pipeline Analysis Overview
- Meril Life Sciences Pvt Ltd - Key Facts
- Meril Life Sciences Pvt Ltd - Major Products and Services
- Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
- Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
- Meril Life Sciences Pvt Ltd Pipeline Products Overview
- CALIX-R
- CALIX-R Product Overview
- Caterpillar
- Caterpillar Product Overview
- Credence BRS
- Credence BRS Product Overview
- Credence BRS Clinical Trial
- CrocoDial Compass
- CrocoDial Compass Product Overview
- Daffodil AV
- Daffodil AV Product Overview
- Daffodil MV
- Daffodil MV Product Overview
- Dafodil DRI
- Dafodil DRI Product Overview
- Ekisu
- Ekisu Product Overview
- Embox
- Embox Product Overview
- Floret BRO
- Floret BRO Product Overview
- Freesia
- Freesia Product Overview
- Interlace BRS
- Interlace BRS Product Overview
- Liana
- Liana Product Overview
- Mammoth NEO
- Mammoth NEO Product Overview
- Mbonest
- Mbonest Product Overview
- Melange BRS
- Melange BRS Product Overview
- Melange BRS Clinical Trial
- MeRes100
- MeRes100 Product Overview
- MeRes100 Clinical Trial
- Meriskin BRS
- Meriskin BRS Product Overview
- Miltonia-UNO
- Miltonia-UNO Product Overview
- Mitva
- Mitva Product Overview
- MyVal 2
- MyVal 2 Product Overview
- MyVal Genesis
- MyVal Genesis Product Overview
- MyVal Hexa
- MyVal Hexa Product Overview
- MyVal Integra
- MyVal Integra Product Overview
- Myval Rondevu
- Myval Rondevu Product Overview
- MyVal S/Ex
- MyVal S/Ex Product Overview
- Navigator 2
- Navigator 2 Product Overview
- Navigator Neo
- Navigator Neo Product Overview
- PeriTi
- PeriTi Product Overview
- Senarius
- Senarius Product Overview
- Zotomime
- Zotomime Product Overview
- Meril Life Sciences Pvt Ltd - Key Competitors
- Meril Life Sciences Pvt Ltd - Key Employees
- Meril Life Sciences Pvt Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Meril Life Sciences Pvt Ltd, Recent Developments
- Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
- Jul 11, 2019: MeRes100 BRS - the world's first thin strut sirolimus-eluting bioresorbable vascular scaffold - shows consistent long-term positive safety with consistent low mace rates and zero scaffold stent thrombosis for patients with coronary artery disease
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
- Table 3: Meril Life Sciences Pvt Ltd Pipeline Products by Indication
- Table 4: Meril Life Sciences Pvt Ltd, Key Facts
- Table 5: Meril Life Sciences Pvt Ltd, Major Products and Services
- Table 6: Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage
- Table 7: Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage
- Table 8: Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
- Table 9: Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary
- Table 10: CALIX-R - Product Status
- Table 11: CALIX-R - Product Description
- Table 12: Caterpillar - Product Status
- Table 13: Caterpillar - Product Description
- Table 14: Credence BRS - Product Status
- Table 15: Credence BRS - Product Description
- Table 16: Credence BRS - To evaluate safety and performance of CREDENCE BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions
- Table 17: CrocoDial Compass - Product Status
- Table 18: CrocoDial Compass - Product Description
- Table 19: Daffodil AV - Product Status
- Table 20: Daffodil AV - Product Description
- Table 21: Daffodil MV - Product Status
- Table 22: Daffodil MV - Product Description
- Table 23: Dafodil DRI - Product Status
- Table 24: Dafodil DRI - Product Description
- Table 25: Ekisu - Product Status
- Table 26: Ekisu - Product Description
- Table 27: Embox - Product Status
- Table 28: Embox - Product Description
- Table 29: Floret BRO - Product Status
- Table 30: Floret BRO - Product Description
- Table 31: Freesia - Product Status
- Table 32: Freesia - Product Description
- Table 33: Interlace BRS - Product Status
- Table 34: Interlace BRS - Product Description
- Table 35: Liana - Product Status
- Table 36: Liana - Product Description
- Table 37: Mammoth NEO - Product Status
- Table 38: Mammoth NEO - Product Description
- Table 39: Mbonest - Product Status
- Table 40: Mbonest - Product Description
- Table 41: Melange BRS - Product Status
- Table 42: Melange BRS - Product Description
- Table 43: Melange BRS - A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery
- Table 44: MeRes100 - Product Status
- Table 45: MeRes100 - Product Description
- Table 46: MeRes100 - A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes - China
- Table 47: MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions: MeRes-1 Extend
- Table 48: MeRes100 - To Compare the Safety and Performance of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions
- Table 49: Meriskin BRS - Product Status
- Table 50: Meriskin BRS - Product Description
- Table 51: Miltonia-UNO - Product Status
- Table 52: Miltonia-UNO - Product Description
- Table 53: Mitva - Product Status
- Table 54: Mitva - Product Description
- Table 55: MyVal 2 - Product Status
- Table 56: MyVal 2 - Product Description
- Table 57: MyVal Genesis - Product Status
- Table 58: MyVal Genesis - Product Description
- Table 59: MyVal Hexa - Product Status
- Table 60: MyVal Hexa - Product Description
- Table 61: MyVal Integra - Product Status
- Table 62: MyVal Integra - Product Description
- Table 63: Myval Rondevu - Product Status
- Table 64: Myval Rondevu - Product Description
- Table 65: MyVal S/Ex - Product Status
- Table 66: MyVal S/Ex - Product Description
- Table 67: Navigator 2 - Product Status
- Table 68: Navigator 2 - Product Description
- Table 69: Navigator Neo - Product Status
- Table 70: Navigator Neo - Product Description
- Table 71: PeriTi - Product Status
- Table 72: PeriTi - Product Description
- Table 73: Senarius - Product Status
- Table 74: Senarius - Product Description
- Table 75: Zotomime - Product Status
- Table 76: Zotomime - Product Description
- Table 77: Meril Life Sciences Pvt Ltd, Key Employees
- Table 78: Meril Life Sciences Pvt Ltd, Subsidiaries
- Table 79: Glossary
- List of Figures
- Figure 1: Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
- Figure 2: Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
- Figure 3: Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.